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Diversity of P1 phage-like elements 
in multidrug resistant Escherichia coli
Carola Venturini1,3*, Tiziana Zingali2,3, Ethan R. Wyrsch2, Bethany Bowring1, Jonathan Iredell1, 
Sally R. Partridge1,3 & Steven P. Djordjevic2,3*
The spread of multidrug resistance via mobile genetic elements is a major clinical and veterinary 
concern. Pathogenic Escherichia coli harbour antibiotic resistance and virulence genes mainly on 
plasmids, but also bacteriophages and hybrid phage-like plasmids. In this study, the genomes of 
three E. coli phage-like plasmids, pJIE250-3 from a human E. coli clinical isolate, pSvP1 from a porcine 
ETEC O157 isolate, and pTZ20_1P from a porcine commensal E. coli, were sequenced (PacBio RSII), 
annotated and compared. All three elements are coliphage P1 variants, each with unique adaptations. 
pJIE250-3 is a P1-derivative that has lost lytic functions and contains no accessory genes. In pTZ20_1P 
and pSvP1, a core P1-like genome is associated with insertion sequence-mediated acquisition of 
plasmid modules encoding multidrug resistance and virulence, respectively. The transfer ability of 
pTZ20_1P, carrying antibiotic resistance markers, was also tested and, although this element was not 
able to transfer by conjugation, it was able to lysogenize a commensal E. coli strain with consequent 
transfer of resistance. The incidence of P1-like plasmids (~7%) in our E. coli collections correlated well 
with that in public databases. This study highlights the need to investigate the contribution of phage-
like plasmids to the successful spread of antibiotic resistant pathotypes.
Escherichia coli is a ubiquitous Gram-negative rod commonly found as a commensal inhabitant of the mamma-
lian gut, but also capable of causing a wide range of diseases (from diarrhea to urinary-tract infections, meningitis 
and sepsis) in both humans and animals1. The global spread of multidrug resistance (MDR) in pathogenic E. coli 
limits treatment options, imposing a significant burden on health and veterinary agencies worldwide2. Successful 
dissemination of E. coli pathotypes depends on the acquisition and carriage of niche-specific traits that allow for 
stable colonization and persistence1,3. The genes encoding such traits are often associated with mobile genetic 
elements (MGEs), such as plasmids and bacteriophages4–6.
In E. coli, MDR spreads predominantly through horizontal gene transfer of antimicrobial resistance genes 
(ARGs), residing on large self-mobilizable plasmids and often co-localized in large complex resistance loci with 
transposons and insertion sequences (IS)6,7. Virulence genes can also be found on the same plasmids as ARGs8,9. 
A crucial evolutionary step in the emergence of highly virulent MDR E. coli clones, a cause of major disease 
outbreaks worldwide, was the acquisition of MDR plasmids10–13. However, other elements of the mobile genome, 
such as bacteriophages, also play a role in the dissemination of these adaptive traits5,14,15, and a better understand-
ing of their diversity and of the extent of their contribution to pathotype adaptation is critical16,17.
Improvements in sequencing technologies, particularly availability of long-read sequencing platforms, have 
allowed the identification of numerous elements combining bacteriophage and plasmid modules in enterobacte-
ria15,18. Many of these phage-like plasmids are derivatives of phages P1 or P7, closely-related temperate coliphages 
of the family Myoviridae19. These prophages infect a wide range of enteric Gram-negative bacteria, including E. coli, 
and are unusual in being commonly found as free circular plasmids stably maintained in bacterial cells without 
integration in the chromosome. Based on the presence of a plasmid replicon and plasmid maintenance genes, 
these elements were classified as belonging to plasmid incompatibility group (Inc) Y19–21 (Fig. 1a). Their stability 
and versatility is enhanced by the presence of a complex immunity circuitry encoded by three loci (ImmI, ImmC 
and ImmT22) and of a variable ‘C-segment’ in the tail fiber-encoding operon19. The immunity functions provide 
protection from infection by foreign DNA and competing phages; the C-segment works like a plasmid shufflon, 
inverted by a site-specific recombinase (Cin in P1, located 5′ to the C-segment), which confers tail fiber variability 
and, consequently, flexible phage host range19,23 (Fig. 1a).
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The unique lifestyle of IncY phage-like plasmids facilitates transduction events24, and, in the era of multidrug 
resistant virulent clones, these elements may play an as-yet-underestimated role in the transfer of resistance and 
virulence genes. The genomes of parents P1 and P7 contain signature mobile elements, e.g. IS1 in P1; IS903 and 
Tn2 with blaTEM-1b (ampicillin resistance) in P7, and phage-like plasmids carrying ARGs linked to transposable 
elements have been sequenced from enteric bacteria isolated worldwide. P1/P7-like elements carrying extended 
spectrum β-lactamase genes have been identified in human clinical E. coli (e.g. blaSHV-225) and Klebsiella pneumo-
niae strains (e.g. blaCTX-M-1526), and in Salmonella from pigs (blaCTX-M-2727), and carrying colistin resistance (mcr-1) 
in E. coli from humans18 and animals28,29, pointing at clinical and livestock reservoirs.
Here, we have carried out detailed comparisons of the genomes of three P1-like elements from Australian 
clinical and veterinary E. coli collections to identify genomic traits that may indicate the adaptive capacities and 
ease of spread/persistence of these elements: pJIE250-3, with no accessory genes, from an MDR E. coli isolated 
from a hospitalized human, and pTZ20_1P carrying ARGs, and pSvP1 carrying ETEC virulence genes, both from 
porcine E. coli.
Figure 1. Comparison of P1-like genomes with coliphage P1 (NC_005856). (a) P1 genome mod749::IS5 c1.100 
thermosensitive mutant19. RD, regions of difference from P1 genome in P1variants. (b) Low G + C content 
regions in the P1 backbone associated with recombination hot-spots (RD1-5). (c) pJIE250-3, from clinical 
human E. coli ST405. The region between the P1-like operons for ‘head processing’ (prt, pro) and ‘lysis’ (lydE, 
lydD, lyz) includes insertion of IS609 (positions 18,574–19,913; cleavage sites: left, TTAT; right, TCAA). (d) 
pSvP1, from porcine ETEC, with IS-mediated rearrangements leading to acquisition of F-type ETEC plasmid 
sequence including enterotoxin genes. From the end of ssb to the start of the ‘C segment’ (18,833–30,870), 
pSvP1 is closely related to P7 (96% overall nucleotide identity) with the addition of an IS10-like element 
(20,058–21,386) and IS609-like sequence (25,544–26,881). (e) pTZ20_1P, from commensal porcine E. coli, 
with plasmid fragments carrying antibiotic resistance genes (ARG). IS-mediated rearrangements led to the 
inversion of the P1 segment between tub and lpa, and deletion of P1-associated orfs (~11 kb encompassing 
the C-segment, tail fibers, ‘base plate and tail tube’ modules). The intergenic region between position 48,153 
and 49,085 has 99% nucleotide identity to that of recently sequenced P1variants, but not P1 itself, and closer 
identity to P7 than P1 prevails in the ‘plasmid replication’, ‘lytic replication’ and ‘antirepressor’ operons. Between 
positions 89,842–89,967, corresponding to the P1 ant1/2 overlapping orfs (immunity determinants), there is 
a small 126-bp gap. Schematics of genome sequences generated using SnapGene Viewer 4.1.4 (GSL Biotech; 
available at snapgene.com), where colors of coding sequences indicate different functional modules. Genome 
comparisons generated using Easyfig visualization tool53. Blue/grey blocks between P1 and each of the three 
P1-like plasmids schematics represent regions of conserved synteny with varying pairwise nucleotide identity 
according to BLASTn [scale bars for direct matches from 100% (dark blue) to 65% (light blue); grey indicates 
matches in reverse orientation].
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Results
Genomes of P1-like plasmids. For all three phage-like elements PacBio sequencing and assembly gen-
erated one contig. E. coli TZ20_1P does not carry any plasmids other than pTZ20_1P, while JIE250, host of 
pJIE250-3, carries an MDR F-type plasmid30 and SvETEC, host of pSvP1, carries MDR IncHI2 and IncI1 plas-
mids31,32 and an FII: (F10:A-:B)-type plasmid encoding additional virulence factors and tetracycline resistance32. 
pJIE250-3, pSvP1 and pTZ20_1P are all variants of coliphage P1 (Fig. 1; Table 1), although some operons in each 
genome have closer identity to P7 (GenBank AF503408; Fig. 1c–e). pJIE250-3 appears to be a P1 derivative that 
has lost lytic replication functions and does not contain any cargo genes. In pSvP1 and pTZ20_1P, the P1-like 
backbone is interrupted by different IS-mediated insertions of plasmid fragments: a large section from an ETEC 
F-type plasmid carrying virulence determinants in the former, and plasmid backbone plus modules carrying 
ARGs in the latter.
Common regions of difference (RD). Comparative analysis with the chosen P1 reference genome19 (P1 
mod749::IS5 c1.100 mutant, GenBank NC_005856) revealed five hot-spots of sequence variation common to 
all three elements (RD-1 to RD-5; Fig. 1a), mainly associated with boundaries between regions of average G+C 
content and AT-rich loci (Fig. 1b). However, in each RD, changes from the P1 backbone were unique for each 
element (Fig. 1c–e; Table 1). The res and mod genes (restriction modification function; RD-1) and IS1 of P1 (RD-
2) are missing from all three elements, replaced by orfs unique to each, but generally highly similar to sequences 
identified in other phage-like plasmids from E. coli (Table 1). Between RD-1 and RD-2, the ‘C1 modulation’ 
(implicated in control of lysogeny), ‘antirestriction’, ‘head processing’, ‘viral architecture’, and ‘lysis’ operons largely 
match those of P1 or P719 (Fig. 1c–e), except for IS609 inserted in pJIE250-3 and pSvP1 (Fig. 1c,d; Table 1). RD-3 
corresponds to the P1 C-segment and adjacent genes, encoding tail structures (fibers, baseplate, tail tube), the 
ImmI-associated region (immunity function: sim operon, icd, ant1/2;), kilA and the ‘lytic replication’ module 
(repL, oriL, rlfA and B)19,22,33 (Fig. 1a). pJIE250-3 has only one tail fiber gene and all other P1 modules are miss-
ing (Fig. 1c). In pSvP1 and pTZ20_1P, RD-3 includes IS-mediated insertions of plasmid backbone fragments 
and associated resistance or virulence genes, with consequent deletion of various segments of the P1 backbone 
(Fig. 1d,e; Table 1). A gene related, but not identical, to cin of P1, encoding the invertase responsible for tail 
switching, was identified in each element (Table 1). However, this gene was truncated (pSvP1; pTZ20_1P) or in 
reverse orientation (pJIE250-3), when compared to P1-cin, and/or its target (C-segment) was greatly modified 
(pJIE250-3 and pTZ20_1P), likely impairing functionality of the switch (Table 1).
RD-4 corresponds to the P1 plasmid replicon (including parAB and repA) and flanking regions (Fig. 1). pJIE250-3 
is almost identical to P1 in this region except for a short insertion 5′ of oriR, containing two orfs. In both pSvP1 and 
pTZ20_1P, the main changes here involve sequences encoding incompatibility determinants, with potential modifica-
tion of replicon function (Table 1). RD-5 is located between pap and lxr, where in all three elements some of the genes 
encoding head morphogenesis in P1 are modified (closer identity to P7) or deleted (Fig. 1; Table 1). Additionally, in 
pTZ20_1P two short hypothetical orfs and a gene encoding an antirepressor (ant) are found inserted in the P1 back-
bone between pacB and c1, as in other phage-like plasmids (e.g. RCS47, NC_042128; Fig. 1e).









cin - C-segment, tail fibers, baseplate 
and tail tube, ImmI, lytic replication 
genes - blpB
58,774–62,949
plasmid partition and 
replication (parSAB, incA, 
repA, incC, oriR)
83,787–86,837





2 orfs including putative 
transcriptional regulator
[16 E. coli MGEs, >98%]
21,420–23,805
2 orfs including 
putative 
phosphohydrolase
[5 E. coli MGEs, 
>99.5%]
31,084–33,367
4 orfs: invertase gene [complement; aa 
98.5% Min p15B X6212161]; tail fiber 
gene [95.2% p15B] plus 2 inverted 
repeats; 2 orfs including antibacterial 
toxin
[E. coli MGEs 94–99%; no match on full 
length]
42,844–43,715
2 orfs [15 E. coli MGEs, 
>99.6%] substitute P1 
sequence preceding oriR 
deleting P1 upfA
64,151–69,831
identity to P7 (≥98% 
nucleotide level with small 
gaps); approximately where 
IS903 is in P7, 2 non-P7 
orfs [Salmonella MGEs 





7 orfs: 5 including homologs 
of P1 icd-ant1/2 [STEC E. 
coli plasmids CP021340 and 
CP021336 91.8%] + 2 including a 
putative transcriptional regulator 
[Klebiella variicola and Serratia 
liquefaciens chromosomes 65.5%; 
aa id to E. coli proteins]
18,834–22,562
2 orfs: P7 nmpC 
interrupted by IS10 
and P7 odaA [P7 
AF503408, 97.9%]
30,866–44,921 + 56,523–65,283
partial invertase orf [N-catalytic domain 
of the P1 Cin Ser-recombinase]; sit 
interrupted by IS2; ISEc84-mediated 
inversion of backbone pmgB to blpB: 
pmgB interrupted by ISEc84; IS186B 
insertion with deletion of rlfA, rlfB 
(lytic replication) and pmgF (putative 
morphogenetic function) substituted by 
2 orfs including antibacterial toxin [E. 
coli MGEs >99%]
48,004–49,273
2 orfs [E. coli MGEs, 
>98%] inserted between 
repA and parA
119,363–126,907
6 orfs including type I 
restriction modification, 
DNA methyltransferase 
substituting pmg genes 
(putative morphogenetic 






2 orfs including a putative
phosphokinase and partial P1-lxc 
homolog
[14 E. coli MGEs >99%]
42,873–43,704
2 orfs unknown 
function: 1, 
interrupts isaA; 2, 
replaces isaB
26,194–26,583 + 84,696–96,450
IS26-mediated rearrangements and 
deletions: Δcin, deleted C-segment-tail 
fibers-baseplate-tail tube, Δtub, Δsit; 
sit-blpB inverted. 3 orfs between repL 
and blpB substitute rlfA-rlfB-pmgF [E. 
coli MGEs CP010146, 99.8%]
75,879–79,888
parAB 99.8% P7 (minimal 
similarity to P1); 
incompatibility regions 
limited identity to P1/
P7 [P7: 5′ parA, 91.6%; 3′ 
parB 81%]
48,154–54,564
8 orfs (pmgU-pap) putative 
morphogenic function 
<40% P1/P7 [E. coli MGE 
CP035333, 99.4%]
Table 1. Main non-P1 features in phage-like plasmids pJIE250-3, pSvP1 and pTZ20_1P*. *Throughout: 
[x,%], best BLASTn matches in the GenBank database (nucleotide percentage identity over 100% length if not 
otherwise stated); aa, BLASTp.
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Unique features of P1-like plasmids. pJIE250-3. In pJIE250-3, five additional orfs are inserted between the c8 
and mat genes at an AT-rich junction, near a cluster of 4× 4-bp direct repeats (DR) (ATTG; 1,957–1,982), close 
to the insertion site of Tn2 in P7. A similar segment was found in nine other E. coli plasmids (e.g. CP032890.1, 
CP019262.1 and MG825383.1, best matches with >99.5% nt identity) and in the chromosome of E. coli ST274734 
(CP007393.1, >99.4% nt identity), and includes genes encoding a putative transcriptional regulator of metabolic 
functions as well as a putative resolvase.
Plasmid sequence in pSvP1. Five copies of ISEc84 (ISEc84.1- ISEc84.5), a member of the IS91-family (rolling 
circle transposition)6,35, are present in RD-3 of pSvP1 and rearrangements mediated by ISEc84 seem to have 
been largely responsible for modification of the P1 backbone here (Fig. 1d; Fig. 2). The P1-like backbone (pmgB 
to upfA) between oppositely-oriented ISEc84.1 and ISEc84.2 is inverted, presumably as a result of IS-mediated 
recombination (Fig. 2). ISEc84.2 is followed by a fragment of the left end (inverted repeat, IRL) of IS3 interrupted 
by IS100, then a region that includes several IS (complete and partial) within a large segment (~41.5 kb; at posi-
tion 67,105) matching F-type plasmids of porcine ETEC [e.g. p14ODTX (MG904993.1; 94,167 bp); pUMNK88_
Ent (CP002732.1; 81,475 bp)36] (Fig. 1d). Addition of this plasmid backbone segment has led to acquisition of a 
new plasmid replicon (repFIB), endotoxin genes (stb, encoding the heat stable enterotoxin II, and eltAB, encoding 
the heat labile enterotoxin), and a toxin-antitoxin stability system. Several other IS, including ISEc84.3, are found 
within this insertion exactly as in the ETEC plasmids (Fig. 2). The acquired plasmid sequence ends at ISEc84.4, 
flanking another partial IS3. This arrangement suggests incorporation of a plasmid-derived circular molecule 
containing ISEc84 within IS3 into a P1-like backbone (Fig. 2) and concomitant deletion of the P1 DNA meth-
ylation operon, phage tRNAs, DNA helicase and part of the ‘baseplate/tail tube’ module (between upfA and 24; 
Fig. 1a,d).
Plasmid sequence in pTZ20_1P. pTZ20_1P contains a sul3 type class 1 integron in which intI1 is truncated by 
IS26 (ΔintI1509) and the cassette array is dfrA12-gcuF-aadA2-cmlA-aadA1-qacI, conferring resistance to trimeth-
oprim, streptomycin and spectinomycin, chloramphenicol and quaternary ammonium compounds. Beyond sul3 
(sulphonamide resistance), the mefB gene is truncated by IS26 (ΔmefB260). Another resistance region includes 
blaTEM-1b (ampicillin resistance), aac(3)-IV (gentamicin and tobramycin resistance) and aph(4)-Ia (hygromycin 
resistance) genes associated with complete and truncated IS and fragments of various Tn3-family transposons 
(Fig. 3). This set of resistance genes fully accounts for the antibiotic resistance phenotype of TZ20_1P.
No DR indicative of insertion were identified adjacent to any mobile elements. However, sequences of the 
expected DR length that are reverse complements of one another are found adjacent to the terminal IR of two 
Tn1722 fragments (5 bp) and two different copies of IS26 (8 bp). This suggests inversions, consistent with the 
comparison between pTZ20_1P and P1 (Fig. 3). Reversing these generates a (presumably ancestral) version of 
pTZ20_1P with three distinct insertions in the P1 backbone. One comprises a 39,980 bp region bookended by 
directly-oriented copies of IS26 and containing the integron and other resistance genes, plus 14,126 bp matching 
part of the tra region of several F-type plasmids in INSDC databases (Fig. 3). This suggests IS26-mediated transfer 
of part of a plasmid to a P1-like backbone. The other two are separate insertions of IS26 and of a complete Tn1722 
Figure 2. Insertion sequences and IS-mediated rearrangements in the pSvP1 genome. IS10 (IRR, 21,385–
21,336, and IRL, 20,057–20,106; 9-bp DR, TGCTCTGCA) interrupts the P7 porin precursor gene nmpC, 
and at 40,334 IS2 interrupts the orf related to P1 sit (5-bp direct repeats, ACCAA). IS186B (IS4 family; 10-bp 
direct repeats, GGATCTCTCC) is inserted between bplB and the ‘lytic replication’ module, causing deletion 
of P1-like sequence associated with lytic replication (rlfA, rlfB) and with putative morphogenetic function 
(pmgF). ISEc84.1 interrupts a P1 pmgB homolog, but the remaining part of pmgB lies adjacent to ISEc84.2 in 
the opposite orientation. As shown, reversing the segment between ISEc84.1 and ISEc84.2 and removing an 
ISEc84 would regenerate a complete pmgB gene. ISEc84 insertion mediated acquisition of a large fragment of 
ETEC plasmid containing multiple IS elements. The region between ISEc84.2 and ISEc84.4 corresponds to 
ETEC plasmid sequence containing multiple IS elements. IS3 fragments (green) flanking these ISEc84 suggest 
insertion of a circular molecule carrying ISEc84 inserted in IS3 (as shown) by recombination in a copy of ISEc84 
in the P1-like backbone. ISEc84 and IS91 may also have been responsible for the acquisition of a region related 
to E. coli IncY MDR plasmid pR15_MCR-1 (95% nucleotide identity; GenBank MK256965.1), containing 
CDSs involved in restriction modification (type I) and DNA methylation with deletion of several P1 pmg genes 
(putative morphogenetic function). Schematic not to scale.
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directly into the P1-like backbone, each flanked by DR. The truncated cin gene and the packase-encoding gene 
pacA (88% nt identity to P1) flank the plasmid insertion (Figs. 1c and 3).
pTZ20_1P self-transfer ability. Induction, lysogeny and conjugation ability were tested using pTZ20_1P, as this 
element carries resistance markers and no additional plasmids were detected in its host, simplifying selection 
strategies. We evaluated whether pTZ20_1P is inducible, treating exponential growth phase cultures with mito-
mycin C or UV light. To confirm the presence of the induced phage-like element in the filtered suspension, we 
performed PCR for the replication genes repA (plasmid) and repL (phage), and linking Tn1722 (plasmid) and the 
pacA gene (phage) (Fig. S1). PCR amplification was successful in all induced cultures, except samples exposed 
to UV light for 20 s (shortest exposure time; Supplementary Fig. S1a). No amplicons were obtained from DNA 
extracted from an un-induced filtered suspension of E. coli TZ20_1P. We tested the ability of pTZ20_1P to lysog-
enize different commensal E. coli host strains. Lysogens were only detected for E. coli WH17, not for E. coli J53 
or WGNB13. PCR amplification of marker genes and whole genome sequencing (WGS) of lysogens confirmed 
the acquisition of pTZ20_1P (Supplementary Fig. S1b). The capacity of pTZ20_1P to transfer by conjugation was 
also tested, but no transconjugants were obtained, as expected due the absence of a complete conjugative transfer 
operon in the inserted plasmid segment (Fig. 3).
Incidence of P1-like plasmids in Australian E. coli. In silico screening of available genome sequences for the 
P1-associated repL (phage) and repA (plasmid) replication genes, identified both in 8/117 (6.8%) isolates from 













































































Figure 3. Multiple antibiotic resistance regions and rearrangements in pTZ20_1P. (a) Schematic of the 
complete pTZ20_1P genome showing insertion points of plasmid regions containing resistance genes, 
transposons and IS. Two oppositely-oriented copies of part of Tn1722 (marked by grey chevrons) are found 
79,484 bp apart and the 5-bp immediately adjacent to the IRL and IRR of Tn1722 are reverse complements of one 
another (AACTA; TGATT). (b) Reversing the region between the Tn1722 fragments (to mimic homologous 
recombination) regenerates a complete Tn1722, with matching 5-bp direct repeats (TGATT) marking the 
insertion. Similarly, reversing a 2,182 bp segment between two inversely-oriented copies of IS26 (to mimic 
intramolecular transposition by IS2660) results in an IS26 flanked by matching 8-bp direct repeats. This, 
presumably ancestral, version of pTZ20_1P corresponds to a P1-like backbone with three separate insertions 
(1) an 39,980 bp region bounded by directly oriented copies of IS26, (2) IS26, and (3) Tn1722. Almost identical 
sequence after the leftmost IS26 through the sul3-type integron to IRL of Tn21 (1) is found in a few Salmonella 
ssp. and E. coli plasmids in INSDC databases. Tn21 truncates Tn1722, which is also truncated by the IRR end 
of Tn5393, with novel boundaries in both cases. Tn5393 is truncated by ISEc59, an IS6 family element, with 
another copy of IS26 flanking a 2,447 bp region containing the aph(4)-Ia and aac(3)-IV genes. The IRR end of 
IS26 truncates the IRL end of Tn2, leaving an intact blaTEM-1b gene. IRR of Tn2 is immediately followed by 49 bp 
of Tn5393 IRL, 106 bp of the IRL end of Tn1722 and 177 bp of the IRL end of IS1. The 14,126 bp region between 
IS1Δ and the next IS26 corresponds to finO-traX-traI-traD-traT-traG-traHΔ genes matching (~98% identity) 
several F-type plasmids in INSDC, some of which have the same boundary with IS1. Diagrams not to scale.
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MDR E. coli and Klebsiella pneumoniae. However, BLASTn searches of the INSDC database (accessed September 
2018) using the same targets returned 54 entries containing both genes (repA >98% identity; repL >97% iden-
tity). Using the search term ‘plasmids Escherichia coli’ to query genome entries in the NCBI database, we found 
1429 sequences annotated as ‘plasmids’. Of these, ~7% had characteristics indicative of phage sequences (e.g. in 
97/1429 (6.7%) t-RNA presence), a frequency comparable to that in our local collections, and 22 of these were 
also identified by the BLASTn screening. Screening for pSvP1 in the genome of sister strain E. coli O157 734/3 
showed the presence of this element in the Australian lineage since 199531.
Discussion
In the era of rising MDR, large conjugative plasmids have been recognized as the main vehicles of antibiotic 
resistance maintenance and transfer, particularly in Enterobacteria. Phages and phage-like plasmids, however, 
may also have a prominent role in the dissemination of accessory adaptive traits5,15,37. Enterobacteria phage P1 
is known to infect and lysogenize E. coli, being maintained within the cell as an autonomous low-copy number 
plasmid19. It does not contain cargo genes of clinical interest and, being a prophage, has not been considered for 
therapeutic applications. Therefore, although P1 was discovered in E. coli over 50 years ago19,22, research efforts 
have mainly focussed on its properties as a molecular biology tool rather than as an active element of the acces-
sory genome22,38,39. However, recent advances in sequencing technologies (e.g. PacBio) have facilitated the detec-
tion of numerous P1-like variants, though detailed characterization has been limited to a few carrying ARGs of 
clinical relevance18,25,27,29. In this study, we defined the fine diversity between three P1-like plasmids from E. coli, 
isolated from different reservoirs (animal and human), with the intention of identifying modifications that may 
associate with pathogen adaptation.
Analysis of pJIE250-3, pTZ20_1P and pSv1P revealed three different variants of P1 sharing common traits. 
pJIE250-3 is an example of a P1-derivative that has lost its lytic replicon, but retained P1 plasmid functions aug-
mented by acquisition of additional plasmid-related orfs (e.g. transcriptional regulators). pTZ20_1P and pSv1P 
are genetic mosaics of P1-like elements and plasmid segments with ARGs and virulence determinants, respec-
tively. The genomes of all three phage-like plasmids are defined by different features unique to each, and none 
has an exact match in INSDC databases. However, each genetic locus is shared with at least two other phage-like 
plasmids, highlighting the variability of phage-like MGEs, testament to their recognised transduction ability19,39. 
Whether this variability is a product of random reassortment due to generalized transduction or a product of the 
adaptive strategy of different pathotypes to their specialized environment is yet to be determined.
The variable regions (RD) distinguishing each element are associated with the same limited number of P1 
genetic loci of low G+C content, where P1 genes previously described as recent acquisitions (e.g. res-mod, sim, 
rfl) are located19. These hot-spots tend to be related to host-range determinants (C-segment; tail fibers), replica-
tion functions (modification of lytic or plasmid replicons), and immunity encoding regions (ImmI specifically). 
Inspection of other P1/P7-like plasmids described in the literature confirms that these RD tend to be shared 
among elements isolated from different E. coli worldwide18,25,28,29. All three P1-like plasmids have a modified tail 
fiber operon when compared to P1, with an altered cin sequence, and lack a complete C-segment locus (tail tip 
switch40). Cin, a P1/P7 specific invertase, is responsible for the production of virions with different host speci-
ficity from the parent, a property presumably lost in these P1 variants, with possible consequent restriction of 
host range. In pJIE250-3, this feature is combined with loss of repL (essential for lytic replication), likely pre-
venting self-mobilization of this element from its host, an E. coli clinical strain carrying multidrug resistance 
on a large F-type conjugative plasmid30. However, pJIE250-3 has retained P1 plasmid loci and acquired several 
additional genes with putative metabolic/DNA processing functions, which could allow for better stability in a 
fixed genomic background.
In P1, the integrity of the plasmid replicon (iterons), partitioning module and plasmid addiction systems, 
including res-mod (notably absent in the three variants), is important to ensure stable plasmid maintenance. 
The absence of res-mod may decrease protection from entry of foreign DNA, but there are indications that the 
additional genes acquired by the P1variants may provide functions facilitating adaptation to local environments 
(e.g. in pSvP1, acquisition of a type I restriction modification system, in pJIE250-3 transcriptional regulators etc.). 
In pSvP1, plasmid functions are also likely enhanced through acquisition of repFIB and additional stability and 
maintenance modules in the inserted plasmid segment.
Negative impact on broad host-range could be associated with modification of the complex P1 immunity 
circuitry protecting the prophage by exclusion of both foreign phage and transducing DNA19. P1 has three immu-
nity encoding regions, Imm I, T and C22,33. ImmC, with C1 repressor of lytic function, and ImmT, implicated in 
C1 modulation, promote plasmid (prophage) maintenance versus entry into the lytic cycle. ImmI (sim, c4, icd, 
ant1/2) has been ascribed a specific role in permitting P1 and P7 coexistence (with minor nucleotide differences 
between P1 and P7 responsible for their reported heteroimmunity) and adding flexibility to ImmC functions33,41. 
P1 and P7 are heteroimmune relatives known to readily recombine42, as evidenced in the genomes of our ele-
ments, but in pJIE250-3 and pSvP1, the ImmI region is modified, possibly compromising superinfection immu-
nity functions. However, interestingly in pJIE250-3 the absence of ImmI is associated with the concomitant loss 
of repL, and in pSvP1 with the acquisition of homologs of P1 genes with putative immunity functions (icd and 
ant1/2 in RD-1).
Here, we showed that P1-like elements in E. coli can co-exist with large plasmids carrying complex resistance 
regions, can pick up different cargo genes (MDR and virulence), and move into a different host. In the lysoge-
nized commensal E. coli WH17, F-type replicons were detected and the MDR transferred as part of pTZ20_1P 
could potentially transfer to these. There have also been reports of transfer of non-conjugative plasmids between 
E. coli cells by transformation mediated by P1 phage lysis43–45, indicating that multiple modes of interaction and 
spread of these elements may shape the adaptive potential of a bacterial population44. Both pJIE250-3 and pSvP1 
were found in the same cell as large plasmids and, provided that they are capable of productive lysis45 (less likely 
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for pJIE250-3 lacking the repL gene), could promote or enhance plasmid movement by these mechanisms. As 
the mammalian gut is an excellent niche for ARG exchange via horizontal transfer, tracking these elements may 
become crucial in responding to the threat of rising MDR in enteric pathogens.
In pTZ20_1P, IS26-mediated transposition events likely led to the acquisition of the multidrug resistance 
region by the P1-like backbone, with IS26 truncating both intI1 (IS26-ΔintI1509) and mefB (IS26-ΔmefB260). The 
presence of an intact PC promoter allows expression of the dfrA12 gene in the cassette array, as confirmed by the 
strain’s antibiotic resistance phenotype (trimethoprim resistance), even though IS26-ΔintI1509 may prevent the 
integration of new gene cassettes into the array. The IS26-ΔmefB260 signature is frequently found on enterobacte-
rial plasmids in combination with sul3, including in porcine and human E. coli4,31,46, while IS26-ΔintI1509 is much 
less common. IS26-ΔmefB260 and IS26-ΔintI1509 together represent a valid signature for tracking this specific 
class 1 integron in different hosts and environments.
The elements described here are examples of how P1 can evolve in different E. coli genomic backgrounds by 
modification of replication and host range properties in association with acquisition of cargo genes, showing that 
P1/P7-like plasmids may not only be capable of generalized transduction, but also be specific vehicles for spread 
and maintenance of virulence and antimicrobial resistance in both clinical and livestock production settings. 
MGEs coexisting within the same host interact with each other, affecting reciprocal stability, and their cooperative 
interactions should be considered when defining bacterial adaptive strategies.
Methods
Bacterial strains. Three E. coli isolates belonging to different sequence types (ST) were host to the three 
P1-like plasmids described here. E. coli TZ20_1P, ST372, phylogroup B2, serotype O6:H31, was isolated in 
January 2017 at the Elizabeth MacArthur Agricultural Institute (EMAI), Menangle, NSW, Australia, from faecal 
material from a healthy four-week-old piglet not previously treated with antimicrobials. E. coli SvETEC ST4245, 
phylogroup C, serotype O157, was also isolated from faecal material from a diarrhoeic piglet, in 200832. E. coli 
JIE250, ST405, phylogroup B2, is a human isolate, part of a large clinical collection of Enterobacteriaceae30. This 
isolate was shown to carry a large conjugative F-type plasmid with a complex MDR region including multiple 
antibiotic resistance genes (e.g. blaCTX-M-15), transposons and IS47.
PacBio sequencing, annotation and bioinformatic analysis of MGEs genomes. Genomic DNA 
was isolated and purified from bacterial cultures grown overnight using the Mo Bio Powersoil® DNA Isolation 
kit (Mo Bio, Carlsbad, CA, USA) or the DNAesy Blood and Tissue kit (Qiagen, Hilden, Germany), according 
to manufacturer’s instructions. Long-read sequencing was performed on the three E. coli isolates on a PacBio 
RSII Instrument at the Ramaciotti Centre for Genomics (UNSW, Sydney, Australia). Polishing and assembly of 
sequenced reads was performed at the Ramaciotti Centre using HGAP and CANU, and plasmids were closed 
using Circlator48. Errors in PacBio assemblies were checked and curated by alignment with Illumina short 
reads from whole genome sequencing of the E. coli hosts. P1-like genomes were first annotated using RASTtk49, 
then manually curated using BLAST functions50, SnapGene (GSL Biotech; available at snapgene.com) and 
Geneious v.9.1 (https://www.geneious.com). Plasmid virulence and resistance regions were also annotated using 
web-based software [Center for Genomic Epidemiology, www.genomicepidemiology.org; GalileoTM AMR (for-
merly MARA), galileoamr.arcbio.com/mara/51]. All allelic variants of IS2652 detected in pTZ20_1P are referred 
to as IS26 throughout. Comparisons with the reference P1 genome (P1 mod749::IS5 c1.100 mutant; GenBank 
NC_005486)19 were visualized using EasyFig.53.
Transfer of pTZ20_1P. Phage induction and lysogenization of commensal E. coli. E. coli TZ20_1P was 
grown in lysogeny broth (LB; Becton Dickinson, Franklin Lakes, NJ, US), with vigorous shaking at 37 °C, to OD600 
0.3, and treated with mitomycin C at 0.05, 0.1, 0.15, or 0.2 μg/mL, or exposed to UV light for 20 s, 45 s or 1 min 
(UV Stratalinker 1800 (230 Vac, 2 A, 50 Hz), Stratagene, CA, US). Induced cultures were incubated at 37 °C for 3 h 
with gentle shaking and centrifuged at 4,000 x g for 20 min to remove bacterial cells debris. Supernatants were fil-
tered and concentrated using 0.22 μm Amicon Ultra-15 filters (Sigma-Aldrich, St. Louis, MO, USA). Suspensions 
were stored overnight at 4 °C prior to lysogenization assays. Three previously characterised commensal E. coli 
strains (WGNB13 and WH1754 and J5355), which are streptomycin susceptible but carry other resistance genes 
suitable for counter-selection, were used as recipients to test the lysogenic ability of pTZ20_1P. Recipient strains 
grown to OD600 0.6 in LB were pelleted by centrifugation and resuspended in LB supplemented with 1 mM CaCl2. 
Bacteria were mixed (1:1) with phage lysates, and the mix was incubated in LB broth (static conditions, 40 min) 
or on LB agar plates (overnight) at 37 °C. E. coli recipients were also mixed with un-induced E. coli TZ20_1P, as 
negative controls. The mixtures were plated on LB agar supplemented with Str 25 μg/mL (selection for phage-like 
plasmid) and incubated at 37 °C for 24 h and 48 h. All transfer experiments were performed in triplicate.
Characterization of lysogenic E. coli. To confirm that the suspension obtained after induction contained 
pTZ20_1P and its consequent stable acquisition by recipient strains, we performed PCR amplification of two 
regions: (1) the plasmid replication gene repA (repA-fw, AAAGCCGAGGGTTACGATGA, and repA-rev, 
ATGATACGGTTTTGCTCGCC; amplicon size 542 bp; this study), and (2) the phage lytic replication gene, repL, 
unique to the P1 component (RepL-fw and RepL-rev25; amplicon size 489 bp). To unequivocally confirm the iden-
tity of the transferred element, we also amplified the region linking plasmid (Tn1722) and phage (pacA) modules 
of this element (Tn1722, CAGACTGGAAGACGGGAAGT; pacA TCAGCCATTTCAGCCACAAC; amplicon 
size 428 bp; this study). Phage DNA was isolated from filtered induced suspensions by treatment with DNAse 
(10 mg/mL; 30 mins) and RNAse (100 mg/mL; 30 mins), followed by extraction and purification using the Wizard 
DNA Clean-up System/kit (Promega, Madison, WI, USA) following manufacturer’s instructions.
8Scientific RepoRtS |         (2019) 9:18861  | https://doi.org/10.1038/s41598-019-54895-4
www.nature.com/scientificreportswww.nature.com/scientificreports/
The genome of one representative E. coli lysogen (E. coli WH17 mitomycin C_0.2 μg/mL) was sequenced to 
confirm pTZ20_1P acquisition. Bacterial DNA was extracted and purified using the ISOLATE II genomic DNA 
kit (Bioline, London, UK). WGS was performed on the Illumina NextSeq (paired-end 150 bp × 2) platform at the 
Pathogen Genomics Unit, Centre for Infectious Disease and Microbiology – Public Health, Westmead Hospital 
(NSW, Australia). Briefly, total DNA concentration was quantified using Quant-it PicoGreen dsDNA Assay Kit 
(Invitrogen, Carlsbad, CA, USA) and 1 ng/µl of DNA was used to prepare DNA libraries using the Nextera XT 
Library Preparation Kit and Nextera XT v2 Indexes (Illumina, San Diego, CA, USA). Multiplexed libraries were 
sequenced using paired end 150 bp chemistry on the NextSeq. 500 NCS v2.0 (Illumina). Error rates were calculated 
using PhiX Sequencing Control v3 for each run. Demultiplexing and FastQC generation was performed automat-
ically by BaseSpace (Illumina). Alignment between the lysogenic genome (raw reads) and the original pTZ20_1P 
PacBio sequence was generated and visualised using Bowtie256 v2.3.0, SAMtools57 v1.4.1, and Tablet58 v1.19.05.28.
Conjugation assay. To assess the ability of pTZ20_1P to transfer via a plasmid-related mobilization mechanism, 
we performed conjugation assays using E. coli EC JM109 RifR/NalR, resistant to rifampicin (Rif) and nalidixic acid 
(Nal) as recipient8. A loopful each of donor (E. coli TZ20_1P) and recipient cultures were mixed thoroughly in 
saline (500 μL), and the mating mix was plated onto LB agar and incubated overnight at 37 °C. The mating lawn 
was resuspended in 1 mL saline and serial dilutions spotted in triplicate onto LB agar plates supplemented with 
Nal (30 μg/mL, Nal30 - recipient selection) and Nal30 plus ampicillin (100 μg/mL, Amp100) or streptomycin (25 μg/
mL, Str25) to detect transconjugants (Nal30Amp100 or Nal30Str25, selection for pTZ20_1P), and LB only agar (total 
bacterial count). Donor and recipient were also separately plated on LB Nal30Amp100, LB Nal30Str25 and LB agar 
only as controls. Conjugation assays were also performed in the presence of E. coli HB101 containing the helper 
plasmid pRK600 with chloramphenicol resistance8,59. Donor and recipient, grown independently under the same 
conditions and plated onto LB supplemented with Str25 and Nal30 respectively, were used as controls.
Occurrence of phage-like plasmids in Australian E. coli collections and NCBI databases. The 
occurrence of P1-like plasmids in available sequences was determined by querying the NCBI bacterial genomes 
database and by in silico BLAST-type searches with repA and repL sequences (minimum percentage identity 95%) 
of representative collections of local E. coli genomes.
Data availability
The complete sequences of pTZ20_1P, pJIE250-3, and pSvP1 have been deposited in GenBank (NCBI) under 
accession numbers MN510447, MN510445, and MN510446 respectively. The complete raw read dataset for 
lysogenic E. coli WH17 mitomycin C_0.2 μg/mL containing pTZ20_1P has been deposited in the SRA (NCBI) 
database under Bioproject PRJNA565856 (SRR10127725). All other data generated or analysed during this study 
are included in this published article (and its Supplementary Information Files).
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